Accretive Health, Inc. (OTCPK:ACHI) is evaluating alternatives and has engaged The Goldman Sachs Group, Inc. (NYSE:GS) as financial advisor to assist in the same. The company stated that it has not made a decision to pursue any specific strategic transaction or any other strategic alternative.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.82 USD | -0.17% | -1.66% | +11.83% |
Apr. 18 | R1 RCM's Q1 Results to Focus on Strategic Alternatives, Change Cyberattack, RBC Says | MT |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.83% | 4.97B | |
-14.73% | 84.87B | |
+16.05% | 83.08B | |
+10.92% | 29.4B | |
-12.73% | 16.72B | |
-3.17% | 16.4B | |
-1.78% | 15.04B | |
+0.13% | 11.88B | |
-31.23% | 11.86B | |
-4.10% | 11.88B |
- Stock Market
- Equities
- RCM Stock
- News R1 RCM Inc.
- Accretive Health Engaged Goldman Sachs For Option Evaluation